In memory
Remembering Dan Fogelberg: Understanding Prostate Cancer
The 'Leader of the Band' singer-songwriter died of prostate cancer in 2007 at 56 — and used his diagnosis to urge men to get checked.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
The news
Dan Fogelberg — the singer-songwriter behind "Leader of the Band," "Same Old Lang Syne," and "Longer" — died on December 16, 2007, at his home in Maine at the age of 56. He had publicly shared in 2004 that he'd been diagnosed with advanced prostate cancer, and in 2005 he announced that treatment had brought the disease into partial remission. The cancer later returned.
After his diagnosis, Fogelberg publicly encouraged men to get screened for prostate cancer — a message his family repeated when announcing his death. That wish, expressed while he was living with the disease, is the reason a piece like this one exists.
Why people are talking about it
Fogelberg's songs are perennials — "Same Old Lang Syne" returns every holiday season — and with them, his story. He was 53 when diagnosed with advanced disease, younger than many people assume prostate cancer patients to be, and he chose to turn his private illness into a public nudge for other men.
What this cancer means
According to the National Cancer Institute, prostate cancer is the most common cancer among men in the United States, and the second leading cause of cancer death in men. NCI also states something that surprises people: prostate cancer usually grows very slowly, and finding and treating it before symptoms occur may not improve men's health or help them live longer.
Those two facts sit in tension, and that tension is real. Many prostate cancers grow so slowly they would never cause harm; some, like the advanced cancer Fogelberg publicly described, are serious. This is why prostate cancer screening is framed as a personal decision to make with a doctor rather than a simple universal rule.
Awareness, screening & prevention
NCI provides evidence-based patient information on prostate cancer screening, including the prostate-specific antigen (PSA) blood test, and on prostate cancer prevention. The heart of its message is balance: screening can find cancer early, but because many prostate cancers would never cause problems, screening also carries the possibility of finding and treating cancers that didn't need treatment. The right choice depends on your age, family history, and values — a genuine conversation, not a checkbox.
Fogelberg's own public request was simply that men have that conversation. You can read about prostate cancer screening in plain language, and our free screening check-up tool can show which screenings are generally recommended at your age.
Common questions
Isn't prostate cancer an old man's disease? It is most common in older men, but Fogelberg was diagnosed in his early fifties. Family history and other factors can shift when the screening conversation should start.
If it usually grows slowly, why worry? Because "usually" isn't "always." NCI notes it remains the second leading cause of cancer death in U.S. men. Slow-growing and serious forms both exist, which is exactly what the screening discussion with a doctor is for.
What did Fogelberg ask of his fans? Publicly, and through his family: that men talk with their doctors about prostate cancer detection. It's a modest ask that takes one appointment.
Questions to ask a healthcare team
- At my age and with my family history, what are the pros and cons of PSA screening for me?
- If a PSA result came back elevated, what would happen next?
- Are there symptoms — urinary changes, pain — I should mention sooner rather than later?
- How often should we revisit the screening decision as I get older?